Glossary#
Session 1 : Introduction to Biological Networks and Knowledge Graphs#
Global concepts across all parts#
Term |
Definition |
|---|---|
Network / graph |
A set of nodes (objects) and edges (pairs of objects that are related). Everything else is derived from those two sets. |
Node / vertex |
One object in the graph. Here: a gene, a disease, or an ICD-10 code. |
Edge |
A relationship between two nodes. |
Degree |
The number of edges attached to a node. A high-degree node is a hub. In a curated graph, degree measures research attention as much as biological importance. |
Path |
A sequence of edges leading from one node to another. Paths let a graph answer questions nobody stored the answer to. |
Connected component |
A group of nodes all reachable from one another. |
Density |
Fraction of possible edges that actually exist. Real biological graphs are sparse (ours: 0.0046). |
Clustering coefficient |
How often a node’s neighbours are themselves connected. Near zero here, because the graph is close to bipartite. |
Directed / undirected |
Whether edges have a direction. |
Self-loop |
An edge from a node to itself. None in this graph. |
— |
— |
Knowledge graph |
A graph whose nodes and edges are typed and carry provenance — we can tell what kind of entity each node is, what kind of relationship each edge is, and on what evidence. |
Computed network |
A network whose edges are calculated from measurements — correlate every pair, keep what clears a threshold. Contrast with curated. |
Curator / curation |
A biologist employed by a database to read published papers and record their findings as structured entries (gene X, disease Y, evidence PMID Z). Also covers automated contributors — text mining, GWAS pipelines. Every edge in a knowledge graph exists because a curator or pipeline put it there. |
Curated network |
A network whose edges are asserted facts read out of a database. Can only contain what somebody already recorded. |
Node type |
The kind of entity a node represents: |
Edge type |
The kind of relationship: |
Provenance |
The evidence attached to an edge — here an association score and an evidence count. |
Bipartite graph |
A graph whose nodes split into two groups with edges only between groups, never within. Genes and diseases here are almost perfectly bipartite. |
Projection |
Collapsing a bipartite graph onto one node type, joining two nodes when they share neighbours. Turns “which diseases resemble each other?” into a structural question. |
Jaccard index |
Size of the intersection divided by size of the union. Used to score shared genes so that well-studied diseases do not automatically rank highest. |
Sparsification |
Removing edges to make a graph readable or to keep only strong relationships — by weight threshold, top percentage, or degree. |
Part 1: What is a Network, and What is a Knowledge Graph?#
Data sources#
Term |
Definition |
|---|---|
Drug-target discovery platform aggregating gene–disease evidence from genetics, somatic mutations, drugs, pathways, expression and literature. Licensed CC0 1.0 (public domain). Source of our genes, diseases, hierarchy and association scores. |
|
Unified disease ontology merging several older vocabularies, and the source of our MONDO → ICD-10 cross-references. Licensed CC BY 4.0. |
|
SSSOM |
Simple Standard for Sharing Ontological Mappings — the file format MONDO publishes its cross-references in ( |
DisGeNET |
A widely cited gene–disease database. Commercially licensed since 2024, so it cannot be redistributed in a public teaching repository. |
Ensembl gene ID |
Stable gene identifier of the form |
TCGA-BRCA |
The Cancer Genome Atlas breast cancer cohort. Source of the expression matrix in |
Co-expression (Part 1 §7)#
Term |
Definition |
|---|---|
Co-expression |
Two genes whose expression rises and falls together across patients. Evidence that they are regulated together — which may mean they work together, or merely that both track a third thing like proliferation. |
Correlation matrix |
Every gene correlated against every other. 737 genes give 271,216 pairs. The diagonal (each gene with itself) is zeroed, otherwise it dominates any ranking. |
Correlation threshold |
The cut-off above which a correlation becomes an edge. There is no principled value. Sweeping 0.3 → 0.8 takes the same data from 39,593 edges to 200, and every one of those networks is defensible. |
Proliferation confound |
The dominant structure in any tumour co-expression network: cell-cycle genes correlate with each other and with anything expressed in dividing cells. Responsible for |
Corroboration |
The same relationship supported by two sources whose errors are independent — e.g. |
Candidate |
A gene co-expressed with a disease’s causal genes that carries no curated edge to that disease. Where gene–disease discovery lives — and where the proliferation confound also lands, indistinguishably. |
Association score |
Open Targets’ 0–1 summary of gene–disease evidence. Not a probability — a weighted aggregation across evidence types, so a high score can reflect genetics or drug treatment. |
Evidence count |
How many individual pieces of evidence support an association. |
Evidence type (datatype) |
The kind of claim behind an association: |
Causal evidence |
|
|
An association arising because a drug hitting this target treats this disease. A statement about therapy, not aetiology — and the reason tubulins look like breast cancer genes. |
Part 2: Building a Knowledge Graph with NetworkX#
Term |
Definition |
|---|---|
NetworkX |
The Python graph library used throughout. |
Node attribute |
Arbitrary data stored on a node — here |
Edge attribute |
Arbitrary data stored on an edge — here |
Unweighted edge |
An edge with no |
Construction artefact |
A property of the graph caused by how it was built rather than by the underlying biology — e.g. diseases are hubs here only because the build kept the top 30 genes per disease. |
Annotation sparsity |
Missing edges that should exist, because nobody has studied the relationship or because the evidence was recorded against a different term. The default state of biomedical knowledge graphs. |
Vocabulary mismatch |
When a fact exists but is filed under an equivalent-but-different ontology term — e.g. basal-like breast carcinoma has zero genes here because the evidence sits on triple-negative breast carcinoma. |
Part 3: Querying the Knowledge Graph#
Term |
Definition |
|---|---|
WHO International Classification of Diseases, 10th revision — the clinical coding system used in hospital records, death certificates and insurance claims. |
|
ICD10CM |
The US “Clinical Modification” of ICD-10, more finely subdivided than the WHO version. |
ICD10WHO |
The WHO’s international version of ICD-10. |
International Classification of Diseases for Oncology — the separate classification that codes tumour morphology. This is where subtype information lives; ICD-10 does not carry it. |
|
Granularity mismatch |
Two vocabularies describing the same thing at different resolutions. ICD-10 subdivides breast cancer anatomically (by quadrant), so it has no code for a molecular subtype — and no data source can supply one. |
Ontology |
A structured vocabulary with defined relationships between terms. The |
|
“X is a kind of Y”. Directional and transitive, which is what makes climbing possible. |
Ancestor |
Any term reachable by following |
Ontology traversal / climbing |
Following |
Inherited mapping |
A code found on an ancestor rather than the node itself. Real, but a weaker claim: it describes the parent, and the mapping is many-to-one. |
Cross-reference (xref) |
A recorded correspondence between a term in one vocabulary and a term in another. |
PAM50 |
A 50-gene expression signature classifying breast tumours into LumA, LumB, Basal, Her2 and Normal. The Session 2 prediction target — and all five labels are disease nodes in this graph. |
Versioned Ensembl ID |
An Ensembl ID carrying an annotation-release suffix ( |
HBOC |
Hereditary Breast and Ovarian Cancer syndrome — driven by BRCA1/BRCA2/BRIP1, and recoverable from this graph purely by asking which genes breast and ovarian cancer share. |
Community detection |
Partitioning a graph into groups of nodes more connected to each other than to the rest. Louvain on our causal projection recovers cancers, autoimmune and metabolic diseases without being told they exist. |
Modularity |
What community detection optimises: how much denser the within-group connections are than chance would give. |
Promiscuous gene |
A gene associated with many unrelated diseases (TP53, tubulins). High degree, low specificity — a shared promiscuous gene rarely means shared biology. |